Mostrar el registro sencillo del ítem

dc.contributor.authorMirón Rubio, Manuel
dc.contributor.authorCeballos Fernández, Rocío
dc.contributor.authorParras Pastor, Inmaculada
dc.contributor.authorPalomo Iloro, Amaya
dc.contributor.authorFernández Félix, Borja Manuel
dc.contributor.authorMedina Miralles, Jenifer
dc.contributor.authorZamudio López, Esther
dc.contributor.authorGonzález Pastor, Javier
dc.contributor.authorAmador Lorente, Caridad
dc.contributor.authorMena Hortelano, Nazaret
dc.contributor.authorDomínguez Sánchez, Alejandro
dc.contributor.authorAlonso Viteri, Soledad
dc.date.accessioned2018-11-19T11:23:01Z
dc.date.available2018-11-19T11:23:01Z
dc.date.issued2018
dc.identifier.issn1747-6356spa
dc.identifier.urihttp://hdl.handle.net/10641/1512
dc.description.abstractBackground: Chronic obstructive pulmonary disease (COPD) is a major consumer of healthcare resources, with most costs related to disease exacerbations. Telemonitoring of patients with COPD may help to reduce the number of exacerbations and/or the related costs. On the other hand, home hospitalization is a cost-saving alternative to inpatient hospitalization associated with increased comfort 15 for patients. The results are reported regarding using telemonitoring and home hospitalization for the management of patients with COPD. Methods: Twenty-eight patients monitored their health parameters at home for six months. A nurse remotely revised the collected parameters and followed the patients as programmed. A home care unit was dispatched to the patients’ home if an alarm signal was detected. The outcomes were compared to 20 historical data from the same patients. Results: The number of COPD exacerbations during the study period did not reduce but the number of hospital admissions decreased by 60% and the number of emergency room visits by 38%. On average, costs related to utilization of healthcare resources were reduced by €1,860.80 per patient per year. Conclusions: Telemonitoring of patients with COPD combined with home hospitalization may allow for AQ425 a reduction in healthcare costs, although its usefulness in preventing exacerbations is still unclearspa
dc.language.isoengspa
dc.publisherExpert Review of Respiratory Medicinespa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectHospital at homespa
dc.subjectHome care unitsspa
dc.subjectHome hospitalizationspa
dc.subjectTelemedicinespa
dc.subjectTelemonitoringspa
dc.titleTelemonitoring and home hospitalization in patients with chronic obstructive pulmonary disease: study TELEPOC.spa
dc.typejournal articlespa
dc.type.hasVersionSMURspa
dc.rights.accessRightsopen accessspa
dc.description.extent664 KBspa
dc.identifier.doi10.1080/17476348.2018.1442214spa


Ficheros en el ítem

FicherosTamañoFormatoVer
IERX_A_1442214.pdf663.0KbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España